Skip to main content
Top
Published in: Archives of Osteoporosis 1/2019

01-12-2019 | Osteoporosis | Original Article

Osteoporosis in colorectal cancer survivors: analysis of the linkage between SWOG trial enrollees and Medicare claims

Authors: Afsaneh Barzi, Dawn L. Hershman, Cathee Till, William E. Barlow, Scott Ramsey, Heinz-Josef Lenz, Howard S. Hochster, Joseph M. Unger

Published in: Archives of Osteoporosis | Issue 1/2019

Login to get access

Abstract

Summary

To explore the rates of osteoporosis (diagnosis and screening) and fractures in colorectal cancer survivors (CRCS), records of clinical trial enrollees was linked to Medicare. Female/male risk of fracture in CRCS is 74% higher than general population. Less than 30% of male and female CRCS receive osteoporosis screening. Osteoporosis is a significant morbidity in CRCS.

Introduction

In the USA, the population of colorectal cancer survivors (CRCS) is on the rise. Calcium and vitamin D are the common thread between colorectal cancer and osteoporosis. We set to explore the patterns and prevalence of osteoporosis (OP) and osteoporotic fractures (OF) in CRCS who received fluorouracil-based therapy on SWOG trials.

Methods

Data for CRCS from three SWOG phase III treatment trials between 1994 and 2000 (N = 3775) were linked to Medicare claims (N = 1233). OP was identified using ICD9 and HCPCS codes; OF was defined using a more restricted set of codes. We compared patterns of OP, OF, and screening for OP by gender in CRCS. Given the gender disparities in the rates of OP and OF, we used data from the National Health Interview Survey (NHIS) and the National Hospital Discharge Survey (NHDS) to assess the ratio of OF in females and males in general population.

Results

Forty-seven percent of females and 15% of men CRCS had OP claims. Female CRCS were more likely than males to have OP (HR = 4.76 [3.77–6.01], p < 0.0001) and OF (HR = 2.64 [2.04–3.42], p < 0.0001). In the general population, the female to male ratio of OF was 1.67 as opposed to 2.90 in CRCS, indicating a significantly larger gender disparity of OF in CRCS (p < 0.001). Only 7% of men and 27% of women CRCS had OP screening.

Conclusion

Despite a low rate of OP screening, the gender disparity of OF in CRCS is more pronounced than the general population. These findings provide an impetus for studying OP and OF in CRCS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66:271–289CrossRef Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66:271–289CrossRef
2.
go back to reference El-Shami K, Oeffinger KC, Erb NL et al (2015) American Cancer Society colorectal cancer survivorship care guidelines. CA Cancer J Clin 65:428–455CrossRef El-Shami K, Oeffinger KC, Erb NL et al (2015) American Cancer Society colorectal cancer survivorship care guidelines. CA Cancer J Clin 65:428–455CrossRef
3.
go back to reference Mincey BA, Duh MS, Thomas SK, Moyneur E, Marynchencko M, Boyce SP, Mallett D, Perez EA (2006) Risk of cancer treatment-associated bone loss and fractures among women with breast cancer receiving aromatase inhibitors. Clin Breast Cancer 7:127–132CrossRef Mincey BA, Duh MS, Thomas SK, Moyneur E, Marynchencko M, Boyce SP, Mallett D, Perez EA (2006) Risk of cancer treatment-associated bone loss and fractures among women with breast cancer receiving aromatase inhibitors. Clin Breast Cancer 7:127–132CrossRef
4.
go back to reference Saylor PJ, Morton RA, Hancock ML, Barnette KG, Steiner MS, Smith MR (2011) Factors associated with vertebral fractures in men treated with androgen deprivation therapy for prostate cancer. J Urol 186:482–486CrossRef Saylor PJ, Morton RA, Hancock ML, Barnette KG, Steiner MS, Smith MR (2011) Factors associated with vertebral fractures in men treated with androgen deprivation therapy for prostate cancer. J Urol 186:482–486CrossRef
5.
go back to reference Hadji P, Coleman RE, Wilson C, Powles TJ, Clézardin P, Aapro M, Costa L, Body JJ, Markopoulos C, Santini D, Diel I, di Leo A, Cameron D, Dodwell D, Smith I, Gnant M, Gray R, Harbeck N, Thurlimann B, Untch M, Cortes J, Martin M, Albert US, Conte PF, Ejlertsen B, Bergh J, Kaufmann M, Holen I (2016) Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European panel. Ann Oncol 27:379–390CrossRef Hadji P, Coleman RE, Wilson C, Powles TJ, Clézardin P, Aapro M, Costa L, Body JJ, Markopoulos C, Santini D, Diel I, di Leo A, Cameron D, Dodwell D, Smith I, Gnant M, Gray R, Harbeck N, Thurlimann B, Untch M, Cortes J, Martin M, Albert US, Conte PF, Ejlertsen B, Bergh J, Kaufmann M, Holen I (2016) Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European panel. Ann Oncol 27:379–390CrossRef
6.
go back to reference Coleman RE, Rathbone E, Brown JE (2013) Management of cancer treatment-induced bone loss. Nat Rev Rheumatol 9:365–374CrossRef Coleman RE, Rathbone E, Brown JE (2013) Management of cancer treatment-induced bone loss. Nat Rev Rheumatol 9:365–374CrossRef
7.
go back to reference Smith MR, Egerdie B, Hernandez Toriz N et al (2009) Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med 361:745–755CrossRef Smith MR, Egerdie B, Hernandez Toriz N et al (2009) Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med 361:745–755CrossRef
8.
go back to reference National Comprehenssive Cancer Networks (NCCN) (2017) Clinical Practice Guidelines in Oncology National Comprehenssive Cancer Networks (NCCN) (2017) Clinical Practice Guidelines in Oncology
9.
go back to reference Ma Y, Zhang P, Wang F, Yang J, Liu Z, Qin H (2011) Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 29:3775–3782CrossRef Ma Y, Zhang P, Wang F, Yang J, Liu Z, Qin H (2011) Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 29:3775–3782CrossRef
10.
go back to reference Woolcott CG, Wilkens LR, Nomura AM et al (2010) Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomark Prev 19:130–134CrossRef Woolcott CG, Wilkens LR, Nomura AM et al (2010) Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomark Prev 19:130–134CrossRef
11.
go back to reference Keum N, Lee DH, Greenwood DC, Zhang X, Giovannucci EL (2015) Calcium intake and colorectal adenoma risk: dose-response meta-analysis of prospective observational studies. Int J Cancer 136:1680–1687CrossRef Keum N, Lee DH, Greenwood DC, Zhang X, Giovannucci EL (2015) Calcium intake and colorectal adenoma risk: dose-response meta-analysis of prospective observational studies. Int J Cancer 136:1680–1687CrossRef
12.
go back to reference Keum N, Aune D, Greenwood DC, Ju W, Giovannucci EL (2014) Calcium intake and colorectal cancer risk: dose-response meta-analysis of prospective observational studies. Int J Cancer 135:1940–1948CrossRef Keum N, Aune D, Greenwood DC, Ju W, Giovannucci EL (2014) Calcium intake and colorectal cancer risk: dose-response meta-analysis of prospective observational studies. Int J Cancer 135:1940–1948CrossRef
13.
go back to reference Maalmi H, Ordonez-Mena JM, Schottker B, Brenner H (2014) Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies. Eur J Cancer 50:1510–1521CrossRef Maalmi H, Ordonez-Mena JM, Schottker B, Brenner H (2014) Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies. Eur J Cancer 50:1510–1521CrossRef
14.
go back to reference Yang B, McCullough ML, Gapstur SM et al (2014) Calcium, vitamin D, dairy products, and mortality among colorectal cancer survivors: the cancer prevention study-II nutrition cohort. J Clin Oncol 32:2335–2343CrossRef Yang B, McCullough ML, Gapstur SM et al (2014) Calcium, vitamin D, dairy products, and mortality among colorectal cancer survivors: the cancer prevention study-II nutrition cohort. J Clin Oncol 32:2335–2343CrossRef
15.
go back to reference Smalley SR, Benedetti JK, Williamson SK, Robertson JM, Estes NC, Maher T, Fisher B, Rich TA, Martenson JA, Kugler JW, Benson AB III, Haller DG, Mayer RJ, Atkins JN, Cripps C, Pedersen J, Periman PO, Tanaka MS Jr, Leichman CG, Macdonald JS (2006) Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 24:3542–3547CrossRef Smalley SR, Benedetti JK, Williamson SK, Robertson JM, Estes NC, Maher T, Fisher B, Rich TA, Martenson JA, Kugler JW, Benson AB III, Haller DG, Mayer RJ, Atkins JN, Cripps C, Pedersen J, Periman PO, Tanaka MS Jr, Leichman CG, Macdonald JS (2006) Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 24:3542–3547CrossRef
16.
go back to reference Poplin EA, Benedetti JK, Estes NC, Haller DG, Mayer RJ, Goldberg RM, Weiss GR, Rivkin SE, Macdonald JS (2005) Phase III Southwest Oncology Group 9415/intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer. J Clin Oncol 23:1819–1825CrossRef Poplin EA, Benedetti JK, Estes NC, Haller DG, Mayer RJ, Goldberg RM, Weiss GR, Rivkin SE, Macdonald JS (2005) Phase III Southwest Oncology Group 9415/intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer. J Clin Oncol 23:1819–1825CrossRef
17.
go back to reference Leichman CG, Benedetti JK, Zalupski MM, Hochster H, Shields AF, Lenz HJ, Wade JL III, Bearden JD III, Macdonald JS (2005) Assessment of infusional 5-fluorouracil schedule and dose intensity: a southwest oncology group and eastern cooperative oncology group study. Clin Colorectal Cancer 5:119–123CrossRef Leichman CG, Benedetti JK, Zalupski MM, Hochster H, Shields AF, Lenz HJ, Wade JL III, Bearden JD III, Macdonald JS (2005) Assessment of infusional 5-fluorouracil schedule and dose intensity: a southwest oncology group and eastern cooperative oncology group study. Clin Colorectal Cancer 5:119–123CrossRef
18.
go back to reference Curtis JR, Taylor AJ, Matthews RS, Ray MN, Becker DJ, Gary LC, Kilgore ML, Morrisey MA, Saag KG, Warriner A, Delzell E (2009) “Pathologic” fractures: should these be included in epidemiologic studies of osteoporotic fractures? Osteoporos Int 20:1969–1972CrossRef Curtis JR, Taylor AJ, Matthews RS, Ray MN, Becker DJ, Gary LC, Kilgore ML, Morrisey MA, Saag KG, Warriner A, Delzell E (2009) “Pathologic” fractures: should these be included in epidemiologic studies of osteoporotic fractures? Osteoporos Int 20:1969–1972CrossRef
19.
go back to reference Sundermeyer ML, Meropol NJ, Rogatko A, Wang H, Cohen SJ (2005) Changing patterns of bone and brain metastases in patients with colorectal cancer. Clin Colorectal Cancer 5:108–113CrossRef Sundermeyer ML, Meropol NJ, Rogatko A, Wang H, Cohen SJ (2005) Changing patterns of bone and brain metastases in patients with colorectal cancer. Clin Colorectal Cancer 5:108–113CrossRef
20.
go back to reference Ramsey-Goldman R, Dunn JE, Dunlop DD, Stuart FP, Abecassis MM, Kaufman DB, Langman CB, Salinger MH, Sprague SM (1999) Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res 14:456–463CrossRef Ramsey-Goldman R, Dunn JE, Dunlop DD, Stuart FP, Abecassis MM, Kaufman DB, Langman CB, Salinger MH, Sprague SM (1999) Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res 14:456–463CrossRef
22.
go back to reference Cox DR (1972) Regression models and life-tables. J R Stat Soc 34:187–220 Cox DR (1972) Regression models and life-tables. J R Stat Soc 34:187–220
23.
go back to reference Kanis JA, Johnell O, Oden A, Sernbo I, Redlund-Johnell I, Dawson A, de Laet C, Jonsson B (2000) Long-term risk of osteoporotic fracture in Malmo. Osteoporos Int 11:669–674CrossRef Kanis JA, Johnell O, Oden A, Sernbo I, Redlund-Johnell I, Dawson A, de Laet C, Jonsson B (2000) Long-term risk of osteoporotic fracture in Malmo. Osteoporos Int 11:669–674CrossRef
24.
go back to reference Melton LJ 3rd, Atkinson EJ, O'Connor MK, O'Fallon WM, Riggs BL (1998) Bone density and fracture risk in men. J Bone Miner Res 13:1915–1923CrossRef Melton LJ 3rd, Atkinson EJ, O'Connor MK, O'Fallon WM, Riggs BL (1998) Bone density and fracture risk in men. J Bone Miner Res 13:1915–1923CrossRef
25.
go back to reference Khan NF, Mant D, Carpenter L, Forman D, Rose PW (2011) Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study. Br J Cancer 105(Suppl 1):S29–S37CrossRef Khan NF, Mant D, Carpenter L, Forman D, Rose PW (2011) Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study. Br J Cancer 105(Suppl 1):S29–S37CrossRef
26.
go back to reference Riggs BL, Khosla S, Melton LJ 3rd. (1998) A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 13:763–773CrossRef Riggs BL, Khosla S, Melton LJ 3rd. (1998) A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 13:763–773CrossRef
27.
go back to reference Sahni S, Mangano KM, McLean RR, Hannan MT, Kiel DP (2015) Dietary approaches for bone health: lessons from the Framingham osteoporosis study. Curr Osteoporos Rep 13:245–255CrossRef Sahni S, Mangano KM, McLean RR, Hannan MT, Kiel DP (2015) Dietary approaches for bone health: lessons from the Framingham osteoporosis study. Curr Osteoporos Rep 13:245–255CrossRef
28.
go back to reference Chakrabarty S, Wang H, Canaff L, Hendy GN, Appelman H, Varani J (2005) Calcium sensing receptor in human colon carcinoma: interaction with Ca(2+) and 1,25-dihydroxyvitamin D(3). Cancer Res 65:493–498PubMed Chakrabarty S, Wang H, Canaff L, Hendy GN, Appelman H, Varani J (2005) Calcium sensing receptor in human colon carcinoma: interaction with Ca(2+) and 1,25-dihydroxyvitamin D(3). Cancer Res 65:493–498PubMed
29.
go back to reference MacLeod RJ, Hayes M, Pacheco I (2007) Wnt5a secretion stimulated by the extracellular calcium-sensing receptor inhibits defective Wnt signaling in colon cancer cells. Am J Physiol Gastrointest Liver Physiol 293:G403–G411CrossRef MacLeod RJ, Hayes M, Pacheco I (2007) Wnt5a secretion stimulated by the extracellular calcium-sensing receptor inhibits defective Wnt signaling in colon cancer cells. Am J Physiol Gastrointest Liver Physiol 293:G403–G411CrossRef
30.
go back to reference Bonovas S, Fiorino G, Lytras T, Malesci A, Danese S (2016) Calcium supplementation for the prevention of colorectal adenomas: a systematic review and meta-analysis of randomized controlled trials. World J Gastroenterol 22:4594–4603CrossRef Bonovas S, Fiorino G, Lytras T, Malesci A, Danese S (2016) Calcium supplementation for the prevention of colorectal adenomas: a systematic review and meta-analysis of randomized controlled trials. World J Gastroenterol 22:4594–4603CrossRef
31.
go back to reference Hoy MK, Goldman JD (2014) Calcium intake of the U.S. population Hoy MK, Goldman JD (2014) Calcium intake of the U.S. population
32.
go back to reference Wu K, Willett WC, Fuchs CS, Colditz GA, Giovannucci EL (2002) Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst 94:437–446CrossRef Wu K, Willett WC, Fuchs CS, Colditz GA, Giovannucci EL (2002) Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst 94:437–446CrossRef
33.
go back to reference Meeker S, Seamons A, Maggio-Price L, Paik J (2016) Protective links between vitamin D, inflammatory bowel disease and colon cancer. World J Gastroenterol 22:933–948CrossRef Meeker S, Seamons A, Maggio-Price L, Paik J (2016) Protective links between vitamin D, inflammatory bowel disease and colon cancer. World J Gastroenterol 22:933–948CrossRef
34.
go back to reference Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, Mullie P, Autier P (2011) Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 128:1414–1424CrossRef Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, Mullie P, Autier P (2011) Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 128:1414–1424CrossRef
35.
go back to reference Jenab M, Bueno-de-Mesquita HB, Ferrari P, van Duijnhoven FJB, Norat T, Pischon T, Jansen EHJM, Slimani N, Byrnes G, Rinaldi S, Tjonneland A, Olsen A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Kaaks R, Linseisen J, Boeing H, Bergmann MM, Trichopoulou A, Misirli G, Trichopoulos D, Berrino F, Vineis P, Panico S, Palli D, Tumino R, Ros MM, van Gils CH, Peeters PH, Brustad M, Lund E, Tormo MJ, Ardanaz E, Rodriguez L, Sanchez MJ, Dorronsoro M, Gonzalez CA, Hallmans G, Palmqvist R, Roddam A, Key TJ, Khaw KT, Autier P, Hainaut P, Riboli E (2010) Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ 340:b5500CrossRef Jenab M, Bueno-de-Mesquita HB, Ferrari P, van Duijnhoven FJB, Norat T, Pischon T, Jansen EHJM, Slimani N, Byrnes G, Rinaldi S, Tjonneland A, Olsen A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Kaaks R, Linseisen J, Boeing H, Bergmann MM, Trichopoulou A, Misirli G, Trichopoulos D, Berrino F, Vineis P, Panico S, Palli D, Tumino R, Ros MM, van Gils CH, Peeters PH, Brustad M, Lund E, Tormo MJ, Ardanaz E, Rodriguez L, Sanchez MJ, Dorronsoro M, Gonzalez CA, Hallmans G, Palmqvist R, Roddam A, Key TJ, Khaw KT, Autier P, Hainaut P, Riboli E (2010) Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ 340:b5500CrossRef
36.
go back to reference Girgis CM, Clifton-Bligh RJ, Mokbel N, Cheng K, Gunton JE (2014) Vitamin D signaling regulates proliferation, differentiation, and myotube size in C2C12 skeletal muscle cells. Endocrinology 155:347–357CrossRef Girgis CM, Clifton-Bligh RJ, Mokbel N, Cheng K, Gunton JE (2014) Vitamin D signaling regulates proliferation, differentiation, and myotube size in C2C12 skeletal muscle cells. Endocrinology 155:347–357CrossRef
37.
go back to reference Ng K, Sargent DJ, Goldberg RM, Meyerhardt JA, Green EM, Pitot HC, Hollis BW, Pollak MN, Fuchs CS (2011) Vitamin D status in patients with stage IV colorectal cancer: findings from intergroup trial N9741. J Clin Oncol 29:1599–1606CrossRef Ng K, Sargent DJ, Goldberg RM, Meyerhardt JA, Green EM, Pitot HC, Hollis BW, Pollak MN, Fuchs CS (2011) Vitamin D status in patients with stage IV colorectal cancer: findings from intergroup trial N9741. J Clin Oncol 29:1599–1606CrossRef
38.
go back to reference Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Alberts SR (2004) A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22:23–30CrossRef Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Alberts SR (2004) A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22:23–30CrossRef
39.
go back to reference Gowda S, Lipka S, Davis-Yadley AH et al (2015) Low bone mineral density linked to colorectal adenomas: a cross-sectional study of a racially diverse population. J Gastrointest Oncol 6:165–171PubMedPubMedCentral Gowda S, Lipka S, Davis-Yadley AH et al (2015) Low bone mineral density linked to colorectal adenomas: a cross-sectional study of a racially diverse population. J Gastrointest Oncol 6:165–171PubMedPubMedCentral
40.
go back to reference Lim JU, Cha JM, Lee JI, Joo KR, Shin HP, Park JJ, Jeon JW (2013) Osteoporosis is associated with the risk of colorectal adenoma in women. Dis Colon Rectum 56:169–174CrossRef Lim JU, Cha JM, Lee JI, Joo KR, Shin HP, Park JJ, Jeon JW (2013) Osteoporosis is associated with the risk of colorectal adenoma in women. Dis Colon Rectum 56:169–174CrossRef
41.
go back to reference Nock NL, Patrick-Melin A, Cook M, Thompson C, Kirwan JP, Li L (2011) Higher bone mineral density is associated with a decreased risk of colorectal adenomas. Int J Cancer 129:956–964CrossRef Nock NL, Patrick-Melin A, Cook M, Thompson C, Kirwan JP, Li L (2011) Higher bone mineral density is associated with a decreased risk of colorectal adenomas. Int J Cancer 129:956–964CrossRef
42.
go back to reference Nevitt MC, Ettinger B, Black DM, Stone K, Jamal SA, Ensrud K, Segal M, Genant HK, Cummings SR (1998) The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 128:793–800CrossRef Nevitt MC, Ettinger B, Black DM, Stone K, Jamal SA, Ensrud K, Segal M, Genant HK, Cummings SR (1998) The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 128:793–800CrossRef
43.
go back to reference Lix LM, Yogendran MS, Leslie WD, Shaw SY, Baumgartner R, Bowman C, Metge C, Gumel A, Hux J, James RC (2008) Using multiple data features improved the validity of osteoporosis case ascertainment from administrative databases. J Clin Epidemiol 61:1250–1260CrossRef Lix LM, Yogendran MS, Leslie WD, Shaw SY, Baumgartner R, Bowman C, Metge C, Gumel A, Hux J, James RC (2008) Using multiple data features improved the validity of osteoporosis case ascertainment from administrative databases. J Clin Epidemiol 61:1250–1260CrossRef
Metadata
Title
Osteoporosis in colorectal cancer survivors: analysis of the linkage between SWOG trial enrollees and Medicare claims
Authors
Afsaneh Barzi
Dawn L. Hershman
Cathee Till
William E. Barlow
Scott Ramsey
Heinz-Josef Lenz
Howard S. Hochster
Joseph M. Unger
Publication date
01-12-2019
Publisher
Springer London
Published in
Archives of Osteoporosis / Issue 1/2019
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-019-0629-7

Other articles of this Issue 1/2019

Archives of Osteoporosis 1/2019 Go to the issue